Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation
- PMID: 18556401
- DOI: 10.3324/haematol.12949
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation
Abstract
Background: Long-term outcome after hematopoietic stem cell transplantation including late transplant-related events is of increasing interest. The aim of this study was to evaluate the incidence of cardiovascular events after allogeneic HSCT and to search for their risk factors.
Design and methods: This is a retrospective multicenter European Group of Blood and Marrow Transplantation (EBMT) analysis, including 548 long-term survivors treated in ten EBMT transplant centers, who underwent hematopoietic stem cell transplantation between 1990 and 1995 and survived >or=1 year after the transplant. All arterial events occurring after hematopoietic stem cell transplantation (cerebral, coronary, peripheral) were reported.
Results: Twenty (3.6%) out of 548 patients had a cardiovascular event in at least one arterial territory. The median age at occurrence of cardiovascular events was 54 years (range, 41-70). The cumulative incidence of a first arterial event 15 years after hematopoietic stem cell transplantation was 6% (95% CI, 3%-10%). The cumulative incidence for patients with a high global cardiovascular risk score, defined as having >or=50% of the risk factors (arterial hypertension, diabetes, dys-lipidemia, increased body-mass index, physical inactivity, smoking) was 17%, as compared to 4% in those with a low risk score. In multivariate analysis age older than 30 years at last follow-up, and a high global cardiovascular risk score were associated with, respectively, 6.4-fold and 9.8-fold increases in the risk of an arterial event.
Conclusions: Long-term survivors after allogeneic hematopoietic stem cell transplantation are likely to have an increased risk of premature cardiovascular accidents.
Comment in
-
Cardiovascular disease after hematopoietic cell transplantation--lessons learned.Haematologica. 2008 Aug;93(8):1132-6. doi: 10.3324/haematol.13514. Haematologica. 2008. PMID: 18669977 No abstract available.
Similar articles
-
Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.J Neurol. 2002 Aug;249(8):1088-97. doi: 10.1007/s00415-002-0800-7. J Neurol. 2002. PMID: 12195460 Clinical Trial.
-
Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2009 Sep;15(9):1100-7. doi: 10.1016/j.bbmt.2009.05.010. Biol Blood Marrow Transplant. 2009. PMID: 19660723
-
Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.J Clin Oncol. 2007 Jun 10;25(17):2449-54. doi: 10.1200/JCO.2006.08.9276. J Clin Oncol. 2007. PMID: 17557958
-
Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.Semin Hematol. 2012 Jan;49(1):25-34. doi: 10.1053/j.seminhematol.2011.10.001. Semin Hematol. 2012. PMID: 22221782 Review.
-
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.Biol Blood Marrow Transplant. 2006 Feb;12(2):138-51. doi: 10.1016/j.bbmt.2005.09.012. Biol Blood Marrow Transplant. 2006. PMID: 16443512
Cited by
-
Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia.Hemasphere. 2024 Oct 22;8(10):e70026. doi: 10.1002/hem3.70026. eCollection 2024 Oct. Hemasphere. 2024. PMID: 39440198 Free PMC article.
-
Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase.PLoS One. 2012;7(1):e30897. doi: 10.1371/journal.pone.0030897. Epub 2012 Jan 27. PLoS One. 2012. PMID: 22303468 Free PMC article.
-
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.Biol Blood Marrow Transplant. 2017 Feb;23(2):201-210. doi: 10.1016/j.bbmt.2016.08.019. Epub 2016 Aug 30. Biol Blood Marrow Transplant. 2017. PMID: 27590105 Free PMC article.
-
Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.Cancer. 2018 Apr 1;124(7):1507-1515. doi: 10.1002/cncr.31227. Epub 2018 Jan 9. Cancer. 2018. PMID: 29315507 Free PMC article.
-
Incidence and risk factors for early-onset hypertension after allogeneic hematopoietic stem cell transplantation in children.Korean Circ J. 2013 Dec;43(12):804-10. doi: 10.4070/kcj.2013.43.12.804. Epub 2013 Dec 20. Korean Circ J. 2013. PMID: 24385991 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources